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Introduction: Intravascular papillary endothelial hyperplasia is a reactive proliferative lesion of endothelial cells in
blood vessels. It typically presents as a painless, reddish purple lesion in the sites affected. The orbit remains an
uncommon site of affectation of this relatively common disease. It is noteworthy that this is the first reported case,
to the best of our knowledge, of orbital intravascular papillary endothelial hyperplasia in a Nigerian child.
Case presentation: The case reported here is an orbital intravascular papillary endothelial hyperplasia causing
non-axial proptosis and loss of vision in a 14-year-old Nigerian boy. We describe the clinical and histological
findings of intravascular papillary endothelial hyperplasia in the orbit of this 14-year-old boy. The key distinguishing
features are discussed and relevant literature is reviewed.
Conclusion: Although unusual in presentation, intravascular papillary endothelial proliferation should be considered
in the list of differentials of proptosis due to mass lesion in young Nigerians and, possibly, Africans.
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Masson’s hemangioma was first described in 1923 by
Pierre Masson as a locally occurring benign tumor in an
ulcerated hemorrhoidal vein of a 68-year-old man [1].
He called it “Hémangioendothéliome Intravasculaire”,
describing it as a form of tumor, due to proliferation of
endothelial cells into the lumen of the vessel with subse-
quent obstruction and secondary degeneration and ne-
crosis. It is a relatively common disorder and has been
described by various names including Masson’s tumor,
Masson’s hemangioma, Masson’s intravascular heman-
gioendothelioma, intravascular papillary endothelial
hyperplasia (IPEH), and reactive papillary endothelial
hyperplasia. However, it is now believed to be a reactive
vascular proliferation following traumatic vascular stasis,
and the current terminology, IPEH, was proposed by
Clearkin and Enzinger [2] in 1976. It has previously been
reported to occur in the extremities, the breast, the thy-
roid gland, the external jugular vein, on the tongue, the* Correspondence: yemifash2000@yahoo.com
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reproduction in any medium, provided the orlip, within the oral cavity, as a neck mass, in paranasal
sinus, intracranially and as a cause of facial nerve palsy
[3-7]. However, in order of decreasing frequency, the le-
sion involves the fingers, head and neck, trunk, lower
extremities and upper extremities [8]. Ocular involve-
ment is unusual, and typically affects the eyelids [9,10].
In this article we report the clinical features, histopath-
ology, and management of a solitary orbital lesion pre-
senting with proptosis and poor vision in a 14-year-old
Nigerian boy and a review of the relevant literature.
Case presentation
An otherwise healthy 14-year-old Nigerian boy, of Yor-
uba ethnic group, presented to our Eye Clinic with a his-
tory of slowly progressive, painless right proptosis
noticed shortly after birth. An increase in the rate of
progression of the proptosis was noticed within the year
of presentation and was associated with mild pain 2
weeks prior to presentation. The vision in his right eye
had been poor since birth, and gradually worsened with
the progressive proptosis. There were no complaints
with his left eye. Specifically, he had no history of
trauma, ear, nose and throat symptoms, swellings intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nificant medical history or history of allergy.
Ocular examination showed visual acuity of counting
fingers at 2 meters in the right eye, about a 15mm non-
axial proptosis that was inferolaterally displaced, palp-
able, mildly tender, and a superonasal, deep orbital mass,
the posterior limit of which could not be delineated.
There were no pulsations or bruit. Ocular motility was
mildly restricted, with conjunctival injection, superficial
punctate keratitis inferiorly, relative afferent papillary de-
fect and clear lens. Fundoscopy revealed mild disc
edema with blurred margins, but the vessels and macula
were normal. The visual acuity in the patient’s left eye
was 6/6, and intraocular pressures were normal in both
eyes. Systemic examination was essentially normal.
An orbital computed tomography scan showed an iso-
dense mass superiorly in the patient’s right orbit with
retro-ocular extension and minimal enhancement with
contrast. There was displacement of his optic nerve
(Figure 1).
The patient subsequently had excision biopsy through
a sub-brow incision where the mass was removed intact.
The intra-operative finding was a well-encapsulated red-
dish brown mass measuring about 40×30×30mm in the
superonasal orbit. He received systemic antibiotics and
analgesics, and had an uneventful post-operative course.
Histopathological examination of sections of the
excised mass showed intravascular papillary prolifera-
tions of endothelial cells, with fibrin thrombi, causing
partial occlusion of the lumen, with recanalization and
extension into the vessel wall (Figures 2a, 2b and 3).
Post-operatively, the proptosis reduced to 3mm, how-
ever, mild restriction of ocular motility and poor visionFigure 1 Computed tomographic scan. There is a superiorly located righ
with contrast.persisted. There was no recurrence after 15 months of
follow-up.
Discussion
IPEH is a reactive proliferative lesion of endothelial cells
in blood vessels. It is a relatively common condition con-
stituting about 2% of the benign and malignant vascular
tumors of the skin and subcutaneous tissues [11]. It
seems to show no gender or age predilection because it
has been reported in males and females ranging in ages
from 9 months to 80 years. However, a female to male
ratio of 1.2:1.0 with an average age of presentation of 34
years has also been reported [12]. Presentation of these
lesions is mainly determined by their site of occurrence,
most cases developing within vascular channels of the
deep dermis or subcutis, and presenting as painless, red-
dish purple lesions, usually in the head and neck region
and extremities [2,3]. Ocular involvement is unusual,
and mostly involves the eyelids [8,9,13], whereas orbital
lesions occur even less commonly [8,13,14].
IPEH had been suggested to represent either a primary
endothelial proliferation with secondary thrombosis or
vice versa. It was originally regarded by Masson [1] to be
a true neoplasm due to endothelial proliferation and sub-
sequent thrombus formation. However, it is now believed
to be a reactive proliferation of endothelial cells that is
associated with organization and recanalization of a
thrombus [4]. The term IPEH, first given by Clearkin and
Enzinger in 1976, [2] is now most widely used to describe
the lesion. However, some authors [5] still consider IPEH
to be a true neoplasm. Also, it has been proposed that
IPEH formation is triggered off with release of basic
fibroblast growth factor by the invading macrophages tot orbital mass with retro-ocular extension and minimal enhancement
ab
Figure 2 a) Photomicrograph of the histology slide (hematoxylin and eosin (H&E) staining) of the lesion. This shows the intravascular
“tumor” with fibrin thrombus. The wall of the artery is seen to the right and the proliferation is to the left of the thrombus. b) Photomicrograph
of the histology slide (H&E staining). Observation of the vascular mass shows proliferation of vascular channels within the lumen and the wall.
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Further release of more basic fibroblast growth factor by
the proliferating endothelial cells occur, cascading into a
positive feedback of endothelial cell proliferation [6].Figure 3 Low-power view (×4) photomicrograph of the lesion. This sh
associated stroma.Three clinical types of this lesion have been described.
[3]. A primary or “pure” form arises within a normal
blood vessel, most commonly a vein, and is often sited
on the fingers, head and neck, and between the elbowsows intravascular papillary proliferation of endothelial cells and
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arises in the setting of a preexisting vascular malforma-
tion, such as a cavernous hemangioma or pyogenic
granuloma and may be sited intramuscularly. The rarest
type, an extravascular hemangioma, usually arises from
an organizing hematoma. Our case could be considered
to be a “mixed” form of IPEH arising on a background
of cavernous hemangioma.
Histologically, IPEH consists of an intravascular prolif-
eration of numerous papillae that are composed of a core
of connective tissue and an endothelial surface. It can be
distinguished from other neoplastic lesions because it is
frequently well-circumscribed or encapsulated, with
characteristic papillary fronds, and the proliferative
process is entirely limited by the vascular wall. There is
also an absence of features of malignancy such as mitotic
figures, necrosis, nuclear pleomorphism, and infiltration
into adjacent tissue [7]. The treatment for IPEH is surgi-
cal excision with complete resection as the goal; this is to
forestall tumor recurrence in incompletely excised
tumors [10]. Our patient underwent complete surgical
excision with no recurrence of the tumor. However, his
visual acuity did not improve post-operatively.
A major differential of IPEH is angiosarcoma. This
however invades tissues outside the vascular channels
and has more than one to two layers of endothelial cells
covering the papillary formation. It also shows more ma-
lignant features on cytology [10].
Conclusions
The first case of orbital involvement of IPEH was first
described by Weber and Babel [14] in 1981. Since then
there have been other reports [10,13] of orbital involve-
ment. However, vision is usually preserved in these
cases, at variance with our case, thus again re-
emphasizing the need for public enlightenment on early
presentation of patients with ophthalmic disorders in
our region to prevent avoidable visual loss [15]. To the
best of our knowledge our case is the first orbital Mas-
son’s hemangioma reported in a Nigerian child.
In conclusion, we report a case of IPEH presenting as
an orbital mass in a 14-year-old Nigerian boy. He under-
went orbitotomy with complete tumor excision and had
an uneventful post-operative period. Late presentation
with attendant ocular morbidity is still a major challenge
in our environment. Intravascular papillary endothelial
proliferation should be considered a differential of prop-
tosis due to mass lesion in young Nigerians and, pos-
sibly, Africans.
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